Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2018-07
-
TGF-β Modulates Sca-1 and Plasticity in Pre-neoplastic Mamma
2026-05-21
This study uncovers how TGF-β signaling regulates the stem cell marker Sca-1 and cellular plasticity in pre-neoplastic mammary epithelial cells. By dissecting the molecular control of Sca-1 expression, the research illuminates mechanisms linking TGF-β activity to tumor initiation and stemness, with implications for targeted pathway modulation in cancer research.
-
Cyclic di-GMP: Intracellular Second Messenger in Biofilm Reg
2026-05-21
Cyclic di-GMP is a well-characterized intracellular second messenger essential for bacterial biofilm formation and genome stability. It functions as a small molecule antitoxin within a unique toxin-antitoxin system, directly controlling antibiotic persistence in biofilms. Its precise mechanistic role and reliable physicochemical properties make it a critical tool for immune modulation research and advanced cancer immunotherapy studies.
-
Deracoxib’s Cytotoxicity in Canine Osteosarcoma: In Vitro In
2026-05-20
This study rigorously compares the cytotoxic effects of Deracoxib and piroxicam on canine osteosarcoma cell lines, establishing Deracoxib’s higher potency at reducing tumor cell viability in vitro without inducing apoptosis. The findings provide a foundation for selective COX-2 inhibitor studies in cancer biology and inform assay design for pain and inflammation research in veterinary oncology.
-
XPO1 Inhibition by Eltanexor Reduces Colorectal Tumorigenesi
2026-05-20
This study demonstrates that Eltanexor (KPT-8602), a second-generation XPO1 inhibitor, effectively reduces colorectal cancer development by modulating the Wnt/β-catenin signaling pathway and suppressing COX-2 expression. The findings provide a mechanistic rationale for targeting nuclear export in chemopreventive strategies for colorectal and potentially other XPO1-driven cancers.
-
ER Stress Suppression Restores Pulmonary Function in CVA via
2026-05-19
This study reveals that Suhuang antitussive capsule protects against pulmonary dysfunction in cough variant asthma (CVA) by inhibiting endoplasmic reticulum (ER) stress, thereby suppressing NLRP3 inflammasome activation. The findings underscore the central role of the RIP1-RIP3-DRP1 axis in linking ER stress to inflammasome-driven inflammation, providing new mechanistic insight for therapeutic intervention in CVA.
-
2-APB: Empowering Mechanistic & Translational Calcium Resear
2026-05-19
Explore how 2-APB (2-aminoethoxydiphenyl borate) transforms the landscape of calcium signaling research, bridging mechanistic insights with actionable strategies for translational scientists. Drawing on recent advances in autophagy-apoptosis modeling and oxidative stress, this thought-leadership article integrates cutting-edge experimental evidence, workflow best practices, and a critical appraisal of the compound’s role in driving innovation beyond standard product narratives.
-
Doxycycline: Tetracycline Antibiotic and Metalloproteinase I
2026-05-18
Doxycycline is a tetracycline antibiotic with broad-spectrum activity and potent metalloproteinase inhibition. It demonstrates antiproliferative effects against cancer cells and is widely used in research for its dual antimicrobial and anticancer properties.
-
0.4% Trypan Blue Solution: Technical Guidance for Cell Viabi
2026-05-18
0.4% Trypan Blue Solution enables practical, membrane-integrity–based cell viability measurement for cell culture and cytotoxicity assays. It is not suitable for diagnostic or clinical applications, and its use should be limited to research workflows requiring rapid discrimination of live and dead cells.
-
GST Inhibition Reveals Mechanisms of Insecticide Resistance
2026-05-17
This study demonstrates that glutathione S-transferase (GST) activity is central to Megalurothrips usitatus resistance against lambda-cyhalothrin, a widely used pyrethroid insecticide. By inhibiting GST with diethyl maleate, the researchers showed a marked reduction in antioxidant defenses and a dramatic increase in insecticide sensitivity, offering mechanistic insight into redox regulation and resistance management.
-
Tin Mesoporphyrin IX: Strategic Inhibition of Heme Oxygenase
2026-05-16
This thought-leadership article explores Tin Mesoporphyrin IX (chloride) as a precision tool for translational researchers investigating heme oxygenase biology in metabolic, inflammatory, and emerging antiviral contexts. By blending mechanistic depth, protocol recommendations, and strategic outlook, it highlights both the opportunities and limitations of deploying this potent heme oxygenase inhibitor in cutting-edge biomedical workflows.
-
Neurotensin (CAS 39379-15-2): Advanced Insights into GPCR Tr
2026-05-15
Explore the sophisticated role of Neurotensin as a Neurotensin receptor 1 activator in dissecting GPCR trafficking and miRNA regulation. This article uniquely bridges mechanistic understanding with evidence-based assay guidance.
-
Scalable Bioreactor Production of iMSC-Derived EVs for Thera
2026-05-15
Gong et al. (2025) present a robust, scalable biomanufacturing system for producing extracellular vesicles (EVs) from induced mesenchymal stem cells (iMSCs) derived from extended pluripotent stem cells (EPSCs). Their platform addresses key bottlenecks in EV therapy—namely donor variability, scalability, and product consistency—offering practical advances for regenerative medicine and translational research.
-
HOXC8 Suppresses Pyroptosis in NSCLC via Caspase-1 Regulatio
2026-05-14
The referenced study uncovers a novel function for the transcription factor HOXC8 in non-small cell lung carcinoma (NSCLC): by recruiting HDAC1/2 to the CASP1 promoter, HOXC8 represses caspase-1 expression, thereby preventing pyroptotic cell death. This mechanistic insight enhances understanding of tumor cell survival and suggests new targets for modulating inflammatory cell death in cancer.
-
Glycogen Colorimetric Assay Kit II: Unveiling Glycogen Dynam
2026-05-14
Explore how the Glycogen Colorimetric Assay Kit II enables high-precision, interference-resistant quantification of glycogen, with a focus on optimizing endurance training research. This article reveals advanced assay considerations and scientific context not found elsewhere.
-
NU6300 Blocks Gasdermin D Pyroptosis via Cysteine-191 Target
2026-05-13
Jiang et al. identify NU6300 as a covalent inhibitor of gasdermin D, revealing a new mechanism that impedes both cleavage and palmitoylation at cysteine-191. These findings advance our understanding of inflammasome-driven pyroptosis and highlight NU6300 as a promising candidate for inflammatory disease intervention.